India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Panacea Biotec receives LoA from CMSS
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies
Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
A joint position paper warns that Europe is the only major global region without a dedicated biomanufacturing initiative
The company’s broader OX2R portfolio includes clinical and preclinical assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions
Subscribe To Our Newsletter & Stay Updated